BRAFV600E-mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response.
Rosa FalconeFederica ConteGiulia FisconValeria PecceMarialuisa SponzielloCosimo DuranteLorenzo FarinaSebastiano FilettiPaola PaciAntonella VerrientiPublished in: Endocrine (2019)
We are persuaded that our network analysis may aid in the comprehension of molecular mechanisms underlying the different responses to vemurafenib in BRAFV600E mutant tumours.
Keyphrases